| Title | Intervention |
NCT ID |
Sponsor | Status |
|---|---|---|---|---|
| New Assessment System in Measuring Symptom Distress in Cancer Patients | Interview, Quality-of-Life Assessment, Questionnaire Administration | NCT00505245 | M.D. Anderson Cancer Center | Recruiting |
| Diet and Physical Activity Change or Usual Care in Improving Progression-Free Survival in Patients... | Behavioral Dietary Intervention, Compliance Monitoring, Counseling, Educational Intervention, Exercise Intervention, Laboratory Biomarker Analysis, Quality-of-Life Assessment, Questionnaire Administration | NCT00719303 | Gynecologic Oncology Group | Recruiting |
| CA-IX, p16, Proliferative Markers, and HPV in Diagnosing Cervical Lesions in Patients With Abnormal... | Cytology Specimen Collection Procedure, Laboratory Biomarker Analysis | NCT00892866 | Gynecologic Oncology Group | Active, not recruiting |
| Trial of Acupuncture for Radiation-Induced Xerostomia in Head and Neck Cancer | Standard Oral Hygiene, Standard Oral Hygiene + Sham Acupuncture, Standard Oral Hygiene + True Acupuncture | NCT01141231 | Wake Forest University Health Sciences | Active, not recruiting |
| Vitamin D and Omega-3 Trial (VITAL) | vitamin D3, omega-3 fatty acids (fish oil), Vitamin D3 placebo, Fish oil placebo | NCT01169259 | Brigham and Women's Hospital | Active, not recruiting |
| Relaxation for Women With Breast Cancer Undergoing Radiotherapy | Relaxation Program, Questionnaires, Saliva Testing | NCT01202851 | M.D. Anderson Cancer Center | Active, not recruiting |
| Controlled Trial Of Acupuncture To Prevent Radiation-Induced Xerostomia | Acupuncture - Group 1, Acupuncture - Group 2, Standard Care, Questionnaire | NCT01266044 | M.D. Anderson Cancer Center | Active, not recruiting |
| Trial of Individual Psychosocial Interventions for Cancer Patients | Individual Meaning-Centered Psychotherapy (IMCP), standard Individual Supportive Psychotherapy (ISP), enhanced usual care (EUC) | NCT01323309 | Memorial Sloan Kettering Cancer Center | Active, not recruiting |
| S0820, Adenoma and Second Primary Prevention Trial | Eflornithine placebo & sulindac, Eflornithine placebo & sulindac placebo, Eflornithine plus sulindac, eflornithine & sulindac placebo | NCT01349881 | Southwest Oncology Group | Recruiting |
| Assessment of Cognitive Function in Breast Cancer and Lymphoma Patients Receiving Chemotherapy | NCT01382082 | University of Rochester NCORP Research Base | Enrolling by invitation |
Why I Joined a Clinical Trial
At the very first mention of my cancer diagnosis, all I could think of was āHow do I beat thisā¦whatās my best course of action?ā A clinical trial was the answer. I had never heard of Multiple Myeloma, so I wasnāt real confident that there would be a trial for me to join. I was so relieved when there was. How could one not benefit from constant monitoring and undergoing extra testing? I have done extremely well and have had no setbacks. I donāt know if I would be in the same spot if it werenāt for the trial. I am so thankful for the doctors and researchers that work tirelessly toward a cure.